Ryan Dobbs
Urology · Geneva, ILNPI 1669815593
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,501 of the $12,144 with a category attached, or 61.8%. Intuitive Surgical accounts for 71.7% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $7,722 and has fallen 72.6% since, to $2,118 in 2025.
Across 38 payments — averaging $319.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Olympus Winter & Ibe GmbH$875
- Cook Incorporated$700
- Boston Scientific$584
- Verathon Inc.$400
- Medtronic$300
- plus $574 from 8 others
What the payments were for
- Consulting fees$1,57513%
- Speaking & faculty fees$7836%
- Travel & lodging$6095%
- Food & beverage$1,67614%
- Education$7,50162%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 17 | $8,710 |
| Olympus Winter & Ibe GmbH | 1 | $875 |
| Cook Incorporated | 1 | $700 |
| Boston Scientific | 9 | $584 |
| Verathon Inc. | 1 | $400 |
| Medtronic | 1 | $300 |
| Olympus America Inc. | 1 | $133 |
| Sanofi | 1 | $125 |
| Coloplast | 1 | $124 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $68 |
| Cook Medical LLC | 1 | $65 |
| Merck | 1 | $44 |
| BD | 1 | $15 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$7,500
- Da Vinci Surgical System$908
- ENDOEYE FLEX DEFLECTABLE VIDEOSCOPE$875
- NPD Clinical Study$400
- AMS 700$148
- iTIND System$133
- AUBAGIO$125
- GENERAL ERECTILE DYSFUNCTION$124
- TITAN$124
How this compares
$12,144 in reported general payments places this provider in the 85th percentile of 550 urology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 21 | $11,223 |
| Tamsulosin Hcl | 104 | $1,739 |
| Finasteride | 31 | $354 |
| Sildenafil Citrate | 14 | $11 |
Paid to pharmacies, not to this prescriber.
Other urology in Geneva
- Mark BrandtPark Ridge$1.3M
- Aaron BergerChicago Ridge$583K
- Gary SteinbergChicago$529K
- Simone CrivellaroChicago$526K
- Brian HelfandChicago$517K
- Ashley RossChicago$404K
- Kevin McVarySpringfield$372K
- Richard HarrisMelrose Park$363K
- Amy KrambeckChicago$356K
- Kevin ZornChicago$274K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.